VRPX insider filings

Virpax Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-07-10. Screen VRPX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VRPX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Virpax Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-07-104Field Katharyn — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-07-094Dhaliwal Jatinder — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-07-094Herman Gary L — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-01-314Singh Vanila — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-314Shah Vinay — Chief Financial OfficerGrant/award (A): 112,000 (derivative) @ $0EDGAR
2024-01-314Jambulingam Thani — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-314Mathias Sheila — Chief Scientific OfficerGrant/award (A): 112,000 (derivative) @ $0EDGAR
2024-01-314Dubin Michael F — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-314Sendrow Jerrold — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-314Floyd Eric — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2024-01-314Ruskin Barbara — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-314Bruce Gerald W — Chief Executive Officer, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2023-08-164/AShah Vinay — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2023-06-214Shah Vinay — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2023-04-264Bruce Gerald W — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2023-03-284Ruskin Barbara — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-02-074/AMack Anthony P. — Chief Executive Officer, Director, 10% ownerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2023-01-274Gudin Jeffrey — Chief Medical Officer, DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2023-01-274Mack Anthony P. — Chief Executive Officer, Director, 10% ownerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2023-01-274Chipman Christopher Michael — Chief Financial OfficerGrant/award (A): 112,000 (derivative) @ $0EDGAR
2023-01-044Jambulingam Thani — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-01-044Floyd Eric — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2023-01-044Sendrow Jerrold — DirectorGrant/award (A): 35,000 (derivative) @ $0EDGAR
2023-01-044Dubin Michael F — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-01-044Singh Vanila — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-05-264Sendrow Jerrold — DirectorPurchase (P): 4,500 @ $1.29EDGAR
2022-05-204Mack Anthony P. — Chief Executive Officer, DirectorPurchase (P): 75,750 @ $1.34EDGAR
2022-05-204Floyd Eric — DirectorPurchase (P): 4,479 @ $1.36EDGAR
2022-04-274Bruce Gerald W — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2022-02-254/AMack Anthony P. — Chief Executive Officer, Director, 10% ownerGrant/award (A): 60,676 (derivative) @ $0EDGAR
2022-02-254/AGudin Jeffrey — Chief Medical Officer, DirectorGrant/award (A): 60,676 (derivative) @ $0EDGAR
2022-02-254/AChipman Christopher Michael — Chief Financial OfficerGrant/award (A): 60,676 (derivative) @ $0EDGAR
2022-02-024Mack Anthony P. — Chief Executive Officer, Director, 10% ownerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2022-02-024Gudin Jeffrey — Chief Medical Officer, DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-02-024Chipman Christopher Michael — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-01-054Sendrow Jerrold — DirectorGrant/award (A): 12,091 (derivative) @ $0EDGAR
2022-01-054Jambulingam Thani — DirectorGrant/award (A): 14,113 (derivative) @ $0EDGAR
2022-01-054Singh Vanila — DirectorGrant/award (A): 12,091 (derivative) @ $0EDGAR
2022-01-054Dubin Michael F — DirectorGrant/award (A): 12,091 (derivative) @ $0EDGAR
2022-01-054Floyd Eric — DirectorGrant/award (A): 15,124 (derivative) @ $0EDGAR
2022-01-054JACOB GARY S — DirectorGrant/award (A): 12,091 (derivative) @ $0EDGAR
2021-11-244Sendrow Jerrold — DirectorPurchase (P): 3,900 @ $3.92EDGAR
2021-11-224Mack Anthony P. — Chief Executive Officer, Director, 10% ownerPurchase (P): 25,125 @ $3.99EDGAR
2021-08-054Dubin Michael F — DirectorGrant/award (A): 20,225 (derivative) @ $0EDGAR
2021-04-094Sendrow Jerrold — DirectorGrant/award (A): 10,205 (derivative) @ $0EDGAR
2021-04-094Floyd Eric — DirectorGrant/award (A): 11,216 (derivative) @ $0EDGAR
2021-04-094Mack Anthony P. — Chief Executive Officer, Director, 10% ownerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2021-04-094Bruce Gerald W — EVP, Commercial OperationsHoldings only — no transactions reportedEDGAR
2021-04-094Chipman Christopher Michael — Chief Financial OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-04-094JACOB GARY S — DirectorGrant/award (A): 13,183 (derivative) @ $0EDGAR

Recent 8-K events — Virpax Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-04-038-K/A3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-04-038-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-218-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-308-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-01-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VRPX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs